Research
Hormonal
Consuming mycoprotein provides a sustained release of essential amino acids (EAAs) and branched-chain amino acids (BCAAs) compared to milk protein, supporting muscle protein synthesis without rapid spikes.
To support muscle growth, include mycoprotein (like Quorn) in your diet. It digests slower than milk or meat, providing a steady stream of amino acids over several hours, which is beneficial for muscle protein synthesis. Aim for 60-80g servings to maximize this effect.
ModerateSupportsMEDIUM confidence
Mycoprotein ingestion resulted in slower but more sustained plasma EAA and BCAA concentrations compared with milk when protein matched. Increasing the dose of mycoprotein amplified these effects, with some evidence of a plateau at 60–80 g
Why this rating
Based on a single small crossover study (n=12) cited in a symposium review.
Source
Mycoprotein: The Future of Nutritious Nonmeat Protein, a Symposium Review
Tim J. A. Finnigan et al. · Current Developments in Nutrition · 2019
DOI 10.1093/cdn/nzz021
narrative_reviewCited 234×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- The incidence of allergic reactions to mycoprotein is exceptionally low (1 in 9 million packages) compared to common allergens, making it a safe novel protein source.Good
- Mycoprotein consumption reduces postprandial insulin response and energy intake at high doses (132g) compared to chicken, without altering glycemic response.Moderate
- Mycoprotein consumption is associated with a significant reduction in plasma cholesterol, particularly in smaller lipoprotein particles, likely due to its high fiber content (chitin and beta-glucans).Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →